GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
4.52M
SGMT
Price
$8.25
Change
+$0.14 (+1.73%)
Updated
Jul 3 closing price
Capitalization
261.1M
52 days until earnings call
Interact to see
Advertisement

GENFF vs SGMT

Header iconGENFF vs SGMT Comparison
Open Charts GENFF vs SGMTBanner chart's image
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$70K
Capitalization4.52M
Sagimet Biosciences
Price$8.25
Change+$0.14 (+1.73%)
Volume$556.04K
Capitalization261.1M
GENFF vs SGMT Comparison Chart in %
Loading...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GENFF vs. SGMT commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENFF is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (GENFF: $0.01 vs. SGMT: $8.25)
Brand notoriety: GENFF and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GENFF: 955% vs. SGMT: 31%
Market capitalization -- GENFF: $4.52M vs. SGMT: $261.1M
GENFF [@Biotechnology] is valued at $4.52M. SGMT’s [@Biotechnology] market capitalization is $261.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GENFF’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • GENFF’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GENFF’s TA Score shows that 2 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • GENFF’s TA Score: 2 bullish, 4 bearish.
  • SGMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than GENFF.

Price Growth

GENFF (@Biotechnology) experienced а -1.75% price change this week, while SGMT (@Biotechnology) price change was -5.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

SGMT is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($261M) has a higher market cap than GENFF($4.52M). SGMT YTD gains are higher at: 83.333 vs. GENFF (-81.426).
GENFFSGMTGENFF / SGMT
Capitalization4.52M261M2%
EBITDAN/A-65.55M-
Gain YTD-81.42683.333-98%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A145M-
Total DebtN/A39K-
TECHNICAL ANALYSIS
Technical Analysis
GENFFSGMT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
33%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
36%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORIC10.800.15
+1.41%
Oric Pharmaceuticals
ZEO2.790.03
+1.09%
Zeo Energy Corp
KMI28.41-0.09
-0.32%
Kinder Morgan
DFH26.12-0.72
-2.68%
Dream Finders Homes
GVH0.08-0.01
-7.80%
Globavend Holdings Limited

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
-1.56%
VRCA - GENFF
23%
Poorly correlated
+9.01%
SGMT - GENFF
10%
Poorly correlated
+1.73%
OCS - GENFF
6%
Poorly correlated
-0.81%
APGE - GENFF
3%
Poorly correlated
+7.08%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with CCCC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+1.73%
CCCC - SGMT
42%
Loosely correlated
-2.63%
TERN - SGMT
40%
Loosely correlated
+1.41%
CRBU - SGMT
39%
Loosely correlated
N/A
VRDN - SGMT
38%
Loosely correlated
+2.89%
OCUL - SGMT
38%
Loosely correlated
+1.69%
More